0001209191-21-067644.txt : 20211202 0001209191-21-067644.hdr.sgml : 20211202 20211202170712 ACCESSION NUMBER: 0001209191-21-067644 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211202 FILED AS OF DATE: 20211202 DATE AS OF CHANGE: 20211202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TRENARY C RUSSELL III CENTRAL INDEX KEY: 0001227307 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37759 FILM NUMBER: 211467633 MAIL ADDRESS: STREET 1: 1700 E ST ANDREW PLACE CITY: SANTA ANA STATE: CA ZIP: 92705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Outlook Therapeutics, Inc. CENTRAL INDEX KEY: 0001649989 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 383982704 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 485 ROUTE 1 SOUTH STREET 2: BUILDING F, SUITE 320 CITY: ISELIN STATE: NJ ZIP: 08830 BUSINESS PHONE: 6096193990 MAIL ADDRESS: STREET 1: 485 ROUTE 1 SOUTH STREET 2: BUILDING F, SUITE 320 CITY: ISELIN STATE: NJ ZIP: 08830 FORMER COMPANY: FORMER CONFORMED NAME: Oncobiologics, Inc. DATE OF NAME CHANGE: 20150804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-02 0 0001649989 Outlook Therapeutics, Inc. OTLK 0001227307 TRENARY C RUSSELL III 485 ROUTE 1 SOUTH, BUILDING F SUITE 320 ISELIN NJ 08830 1 1 0 0 CEO and President Common Stock 2021-12-02 4 P 0 10000 1.40 A 10000 D /s/ Lawrence Kenyon, Attorney-in-Fact 2021-12-02